Moreno Lanceta, A. (2024). Novel carbon-based nanoscale therapeutics for the modulation of macrophages in liver inflammation, fibrosis, and regeneration.
Citación estilo ChicagoMoreno Lanceta, Alazne. Novel Carbon-based Nanoscale Therapeutics for the Modulation of Macrophages in Liver Inflammation, Fibrosis, and Regeneration. 2024.
Cita MLAMoreno Lanceta, Alazne. Novel Carbon-based Nanoscale Therapeutics for the Modulation of Macrophages in Liver Inflammation, Fibrosis, and Regeneration. 2024.
Precaución: Estas citas no son 100% exactas.